Licensing Red/ET Recombination

Gene Bridges GmbH owns the exclusive rights to Red/ET Recombination, a revolutionary DNA engineering technology. Gene Bridges issues licenses for the use of the Red/ET Recombination technology to commercial users. Licensing arrangements for Red/ET Recombination are provided as world-wide, non-exclusive sub-licenses.


Full commercial license


6-Month trial license


Licenses KEIO collection


For more information please contact licenses@genebridges.com

To the top

Please choose your country. If the country is missing, continue.

Shanghai QF Biosciences
Shanghai QF Biosciences
NeuProCell
Biotech Desk
NeuProCell
Biotech Desk
BioTag
BioTag
Funakoshi
Funakoshi
Mbiotech
Mbiotech
iDNA
iDNA
iDNA
iDNA
iDNA
iDNA
iDNA
iDNA
Gendiscovery
Gendiscovery
BioCat
BioCat
BioCat
BioCat
BioCat
BioCat
Biovalley
Biovalley
Quimigen
Quimigen
Brunschwig Chemie
Brunschwig Chemie
Cambio
Cambio
Cambio
Cambio
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Nanodiagnostika
Immuno Diagnostic
Nanodiagnostika
Nanodiagnostika
Nanodiagnostika
Nanodiagnostika
Nanodiagnostika
B-Bridge International
B-Bridge International
Valquim
Valquim